# Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine

> **NCT01010893** · NA · COMPLETED · sponsor: **Fluart Innovative Vaccine Ltd, Hungary** · enrollment: 355 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Vaccination with Fluval P and Fluval AB influenza vaccines
- **BIOLOGICAL:** Vaccination with Fluval P monovalent influenza vaccine

## Key facts

- **NCT ID:** NCT01010893
- **Lead sponsor:** Fluart Innovative Vaccine Ltd, Hungary
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-09
- **Final completion:** 2010-02
- **Target enrollment:** 355 (ACTUAL)
- **Last updated:** 2012-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010893, "Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01010893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*